Steward Partners Investment Advisory’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.5K | Buy |
5,663
+5,000
| +754% | +$41.1K | ﹤0.01% | 2519 |
|
|
2025
Q1 | $4.74K | Buy |
663
+400
| +152% | +$2.86K | ﹤0.01% | 3397 |
|
|
2024
Q4 | $2.03K | Sell |
263
-26,100
| -99% | -$202K | ﹤0.01% | 3628 |
|
|
2024
Q3 | $277K | Sell |
26,363
-1,500
| -5% | -$15.7K | ﹤0.01% | 1366 |
|
|
2024
Q2 | $326K | Buy |
27,863
+19,600
| +237% | +$229K | ﹤0.01% | 1244 |
|
|
2024
Q1 | $174K | Buy |
8,263
+8,000
| +3,042% | +$169K | ﹤0.01% | 1505 |
|
|
2023
Q4 | $4.72K | Sell |
263
-50
| -16% | -$898 | ﹤0.01% | 2980 |
|
|
2023
Q3 | $5.15K | Buy |
313
+113
| +57% | +$1.86K | ﹤0.01% | 2810 |
|
|
2023
Q2 | $4K | Hold |
200
| – | – | ﹤0.01% | 2862 |
|
|
2023
Q1 | $3.78K | Hold |
200
| – | – | ﹤0.01% | 2869 |
|
|
2022
Q4 | $4.54K | Sell |
200
-120
| -38% | -$2.72K | ﹤0.01% | 2806 |
|
|
2022
Q3 | $8K | Hold |
320
| – | – | ﹤0.01% | 2622 |
|
|
2022
Q2 | $8K | Hold |
320
| – | – | ﹤0.01% | 2605 |
|
|
2022
Q1 | $11K | Buy |
320
+100
| +45% | +$3.44K | ﹤0.01% | 2631 |
|
|
2021
Q4 | $7K | Sell |
220
-150
| -41% | -$4.77K | ﹤0.01% | 2733 |
|
|
2021
Q3 | $16K | Buy |
370
+120
| +48% | +$5.19K | ﹤0.01% | 2427 |
|
|
2021
Q2 | $10K | Sell |
250
-1,850
| -88% | -$74K | ﹤0.01% | 6064 |
|
|
2021
Q1 | $71.6K | Buy |
+2,100
| New | +$71.6K | ﹤0.01% | 1799 |
|